Trogenix Ltd
Research and experimental development on biotechnology · London
ActiveUnited KingdomIncorporated 2023Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2023-12-31
IXBRL · 26 source facts · 3 selected values
Not assessedlegacy record
Accounts to 2023-12-31
IXBRL · 26 source facts · 3 selected values
Not assessed
legacy record
- Reporting period
- 2023-06-12 to 2023-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 5
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3200_14930146_20231231
- Source archive
- Accounts_Monthly_Data-December2024.zip
Registered details
14930146- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2023-06-12
- Jurisdiction
- —
- Registered office
- FIRST FLOOR, 5 FLEET PLACE, LONDON, EC4M 7RD, UNITED KINGDOM
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
1 matched grantsDevelopment of a novel AAV cancer gene therapy for liver hepatocellular carcinoma and colorectal cancerLead
Innovate UK · Collaborative R&D · 2024-02-01 – 2026-01-31
£767,492
awarded